Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹52 Cr₹54 Cr₹46 Cr₹22 Cr₹24 Cr

What is the latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS is ₹52 Cr based on Mar2025 Standalone results.
Year Total Current Liabilities
Mar2025₹52 Cr
Mar2024₹54 Cr
Mar2023₹46 Cr
Mar2022₹22 Cr
Mar2021₹24 Cr

How is Total Current Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2025 ₹52 Cr
-4.13
Mar2024 ₹54 Cr
16.37
Mar2023 ₹46 Cr
111.13
Mar2022 ₹22 Cr
-9.45
Mar2021 ₹24 Cr -

Compare Total Current Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹493.7 Cr 21.5% 54.9% 161.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 0.5% 1.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -3.3% -3.5% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 4.5% 2.6% 42.6% Stock Analytics
CIPLA ₹117,420.0 Cr 2.7% 2.5% -4% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.6% 4.3% 1.9% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

21.5%

54.9%

161.9%

SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses